Raily Aesthetic Medicine International Holdings Limited

As of December 31, 2025, Raily Aesthetic Medicine International Holdings Limited carries a market capitalization of 86.41M, placing it among publicly traded companies globally. Its enterprise value stands at 77.27M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Raily Aesthetic Medicine International Holdings Limited has 557.08M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Raily Aesthetic Medicine International Holdings Limited maintains a current ratio of 0.77, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Raily Aesthetic Medicine International Holdings Limited's stock has declined approximately 5.41% over the past 52 weeks. The 50-day moving average sits at 0.11, while the 200-day moving average is 0.13.

As of December 31, 2025, Raily Aesthetic Medicine International Holdings Limited holds 64.32M in cash and equivalents against 65.83M in total debt, resulting in a net debt position of -40.42M. Total book value stands at 120.00M, with working capital of -32.51M providing operational flexibility.

Raily Aesthetic Medicine International Holdings Limited's most recent stock split took place on March 20, 2024.